Sanjiv Patel, Director, President, and CEO, on September 08, 2026, sold 48,199 shares in Relay Therapeutics (RLAY) for $912,889. Following the Form 4 filing with the SEC, Patel has control over a total of 1,406,403 common shares of the company, with 519,500 shares held directly and 886,903 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1812364/000119312526386455/xslF345X05/ownership.xml